These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 31279179)
1. Recent advances in biosensor for detection of lung cancer biomarkers. Yang G; Xiao Z; Tang C; Deng Y; Huang H; He Z Biosens Bioelectron; 2019 Sep; 141():111416. PubMed ID: 31279179 [TBL] [Abstract][Full Text] [Related]
2. Sub-femtomolar vertical graphene field effect immunosensor for detection of lung tumor markers. Liu R; Song H; Wu H; Yang Z; Fang S; Zhu J; Ba L Talanta; 2024 Oct; 278():126498. PubMed ID: 38959668 [TBL] [Abstract][Full Text] [Related]
3. Recent Progress in Biosensors for Detection of Tumor Biomarkers. Li M; Jiang F; Xue L; Peng C; Shi Z; Zhang Z; Li J; Pan Y; Wang X; Feng C; Qiao D; Chen Z; Luo Q; Chen X Molecules; 2022 Oct; 27(21):. PubMed ID: 36364157 [TBL] [Abstract][Full Text] [Related]
4. Early detection of lung cancer biomarkers through biosensor technology: A review. Roointan A; Ahmad Mir T; Ibrahim Wani S; Mati-Ur-Rehman ; Hussain KK; Ahmed B; Abrahim S; Savardashtaki A; Gandomani G; Gandomani M; Chinnappan R; Akhtar MH J Pharm Biomed Anal; 2019 Feb; 164():93-103. PubMed ID: 30366148 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Lee JH; Chang JH Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887 [TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients. Hillas G; Moschos C; Dimakou K; Vlastos F; Avgeropoulou S; Christakopoulou I; Rasidakis A; Bakakos P Scand J Clin Lab Invest; 2008; 68(7):542-7. PubMed ID: 19378425 [TBL] [Abstract][Full Text] [Related]
7. Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels. Liu L; Wu S; Jing F; Zhou H; Jia C; Li G; Cong H; Jin Q; Zhao J Biosens Bioelectron; 2016 Jun; 80():300-306. PubMed ID: 26852198 [TBL] [Abstract][Full Text] [Related]
8. Electrochemical biosensors for the detection of lung cancer biomarkers: A review. Khanmohammadi A; Aghaie A; Vahedi E; Qazvini A; Ghanei M; Afkhami A; Hajian A; Bagheri H Talanta; 2020 Jan; 206():120251. PubMed ID: 31514848 [TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study. Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. Seemann MD; Beinert T; Fürst H; Fink U Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum tumor markers in patients with lung cancer. Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM Respiration; 2002; 69(1):25-9. PubMed ID: 11844959 [TBL] [Abstract][Full Text] [Related]
12. [Usefulness and limitation of serum tumor markers in diagnosis of lung cancer]. Fukuda M; Oka M Nihon Rinsho; 1996 Jun; 54(6):1610-5. PubMed ID: 8691617 [TBL] [Abstract][Full Text] [Related]
13. Highly sensitive detection of multiple tumor markers for lung cancer using gold nanoparticle probes and microarrays. Gao W; Wang W; Yao S; Wu S; Zhang H; Zhang J; Jing F; Mao H; Jin Q; Cong H; Jia C; Zhang G; Zhao J Anal Chim Acta; 2017 Mar; 958():77-84. PubMed ID: 28110687 [TBL] [Abstract][Full Text] [Related]
14. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318 [TBL] [Abstract][Full Text] [Related]
15. Electrochemical biosensors for measurement of colorectal cancer biomarkers. Zhang W; Xiao G; Chen J; Wang L; Hu Q; Wu J; Zhang W; Song M; Qiao J; Xu C Anal Bioanal Chem; 2021 Apr; 413(9):2407-2428. PubMed ID: 33666711 [TBL] [Abstract][Full Text] [Related]
16. Early lung cancer diagnosis by biosensors. Zhang Y; Yang D; Weng L; Wang L Int J Mol Sci; 2013 Jul; 14(8):15479-509. PubMed ID: 23892596 [TBL] [Abstract][Full Text] [Related]
17. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Pujol JL; Boher JM; Grenier J; Quantin X Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401 [TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Plebani M; Basso D; Navaglia F; De Paoli M; Tommasini A; Cipriani A Br J Cancer; 1995 Jul; 72(1):170-3. PubMed ID: 7541234 [TBL] [Abstract][Full Text] [Related]
19. Multiplexed detection of lung cancer biomarkers based on quantum dots and microbeads. Wu S; Liu L; Li G; Jing F; Mao H; Jin Q; Zhai W; Zhang H; Zhao J; Jia C Talanta; 2016 Aug; 156-157():48-54. PubMed ID: 27260434 [TBL] [Abstract][Full Text] [Related]
20. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. Wang WJ; Tao Z; Gu W; Sun LH Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]